M3, Inc. (TYO:2413)
Japan · Delayed Price · Currency is JPY 1,784.50
-35.50 (-1.95%)
Nov 4, 2026, 3:30 PM JST
M3, Inc. Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 355,268 | 351,363 | 284,900 | 238,883 | 230,818 | 208,159 |
Revenue Growth | 15.76% | 23.33% | 19.26% | 3.49% | 10.88% | 23.03% |
Gross Profit Gross Profit Growth | 175,728 | 175,844 | 154,364 | 140,531 | 135,186 | 123,268 |
Operating Income Operating Income Growth | 68,488 | 70,680 | 62,066 | 65,638 | 70,415 | 67,364 |
Net Income Net Income Growth | 46,334 | 49,100 | 40,484 | 45,271 | 49,028 | 63,845 |
Earnings Per Share EPS Growth | 68.71 | 72.50 | 59.60 | 66.63 | 72.17 | 93.98 |
EPS Growth | 13.61% | 21.64% | -10.55% | -7.68% | -23.21% | 68.79% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Medical Platform Segment Medical Platform Segment Growth | 108,141 | 107,830 | 91,566 | 93,414 | 93,098 | 85,928 |
Evidence Solution Segment Evidence Solution Segment Growth | 23,993 | 24,521 | 24,244 | 26,700 | 27,157 | 22,756 |
Career Solution Segment Career Solution Segment Growth | 22,518 | 22,799 | 20,914 | 16,642 | 14,538 | 14,094 |
Site Solution Segment Site Solution Segment Growth | 55,516 | 54,353 | 47,043 | 33,025 | 35,295 | 35,184 |
Patient Solution Segment Patient Solution Segment Growth | 58,207 | 56,877 | 21,919 | - | - | - |
Overseas Segment Overseas Segment Growth | 88,944 | 86,921 | 80,570 | 69,868 | 62,095 | 51,831 |
Other Emerging Businesses Segment Other Emerging Businesses Segment Growth | 2,217 | 2,230 | 2,453 | 2,633 | 3,284 | 3,360 |
Adjustments to Segment Adjustments to Segment Growth | -4,268 | -4,168 | -3,809 | -3,399 | -4,649 | -4,994 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 162,174 | 156,177 | 134,933 | 149,661 | 118,319 | 104,253 |
Total Debt Total Debt Growth | 37,556 | 60,494 | 51,417 | 31,783 | 10,382 | 8,297 |
Net Cash (Debt) Net Cash Growth | 124,618 | 95,683 | 83,516 | 117,878 | 107,937 | 95,956 |
Net Cash Growth | 63.97% | 14.57% | -29.15% | 9.21% | 12.49% | 19.76% |
Net Cash Per Share Net Cash Per Share Growth | 184.81 | 141.29 | 122.96 | 173.49 | 158.89 | 141.25 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 70,262 | 51,743 | 58,310 | 57,113 | 52,108 |
Capital Expenditures CapEx Growth | - | -7,680 | -6,290 | -5,412 | -5,911 | -1,705 |
Free Cash Flow Free Cash Flow Growth | - | 62,582 | 45,453 | 52,898 | 51,202 | 50,403 |
Free Cash Flow Growth | - | 37.69% | -14.07% | 3.31% | 1.58% | 11.03% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 49.46% | 50.05% | 54.18% | 58.83% | 58.57% | 59.22% |
Operating Margin | 19.28% | 20.12% | 21.79% | 27.48% | 30.51% | 32.36% |
Pretax Margin | 21.18% | 21.71% | 22.74% | 28.82% | 32.20% | 46.21% |
Profit Margin | 13.04% | 13.97% | 14.21% | 18.95% | 21.24% | 30.67% |
FCF Margin | - | 17.81% | 15.95% | 22.14% | 22.18% | 24.21% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 22.000 | 22.000 | 21.000 | 21.000 | 19.000 | 16.000 |
Dividend Per Share Growth | 4.76% | 4.76% | 0% | 10.53% | 18.75% | 33.33% |
Dividend Yield | 1.23% | 1.37% | 1.23% | 0.98% | 0.58% | 0.36% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 25.97 | 21.82 | 28.55 | 32.05 | 45.71 | 47.51 |
Forward PE | 22.94 | 20.31 | 23.53 | 27.15 | 43.58 | 54.03 |
P/FCF Ratio | 19.20 | 17.12 | 25.43 | 27.43 | 43.77 | 60.18 |
PS Ratio | 3.38 | 3.05 | 4.06 | 6.07 | 9.71 | 14.57 |